Vanguard Group Inc. Purchases 1,029,829 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Vanguard Group Inc. lifted its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 5.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,463,155 shares of the health services provider's stock after buying an additional 1,029,829 shares during the period. Vanguard Group Inc. owned approximately 10.72% of Teladoc Health worth $167,830,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. Versant Capital Management Inc increased its holdings in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after buying an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC bought a new stake in shares of Teladoc Health during the 4th quarter valued at $29,000. Lindbrook Capital LLC increased its stake in shares of Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after purchasing an additional 1,612 shares in the last quarter. Generali Investments Management Co LLC bought a new position in Teladoc Health in the 4th quarter worth $64,000. Finally, PNC Financial Services Group Inc. raised its holdings in Teladoc Health by 22.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider's stock worth $73,000 after purchasing an additional 1,439 shares during the period. Institutional investors own 76.82% of the company's stock.

Remove Ads

Teladoc Health Trading Up 0.2 %

TDOC stock traded up $0.02 during mid-day trading on Friday, reaching $7.26. 5,040,718 shares of the stock traded hands, compared to its average volume of 6,248,499. Teladoc Health, Inc. has a one year low of $6.61 and a one year high of $15.21. The stock has a market capitalization of $1.26 billion, a PE ratio of -1.26 and a beta of 1.73. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The business has a 50-day moving average price of $9.73 and a two-hundred day moving average price of $9.69.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million for the quarter, compared to analysts' expectations of $639.44 million. Equities research analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Piper Sandler reduced their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Oppenheimer decreased their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research note on Friday, January 24th. Bank of America dropped their price target on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a research report on Friday. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. Finally, The Goldman Sachs Group dropped their target price on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a report on Monday, March 3rd. Eleven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $10.94.

Insider Activity

In other news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This trade represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.95% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.